Impact Partnership Wealth
UTHR icon

Impact Partnership Wealth’s United Therapeutics UTHR Stock Holding History

Impact Partnership Wealth’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$270K Buy
498
+113
+29% +$58.4K 0.02% 380
2026
Q2 		$209K Buy
+385
New +$217K 0.02% 414
2025
Q1 		– Sell
-974
Closed -$344K – 344
2024
Q4 		$344K Buy
974
+265
+37% +$97.4K 0.07% 182
2024
Q3 		$254K Buy
+709
New +$239K 0.06% 200
2024
Q2 		– Sell
-2
Closed -$459 – 655
2024
Q1 		$459 Sell
2
-479
-100% -$108K ﹤0.01% 656
2023
Q4 		$106K Buy
+481
New +$111K 0.04% 237

Other funds holding UTHR

Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Impact Partnership Wealth's UTHR Position: Q3 2026 in Review

Impact Partnership Wealth increased its United Therapeutics (UTHR) stake by 29% in Q3 2026, buying an estimated $58.4K and bringing the position to 498 shares worth $270K. The position accounts for 0.02% of the portfolio, ranked #380.

Impact Partnership Wealth first reported a position in UTHR in Q4 2023 and has held it in 6 quarters since. The position peaked at $344K in Q4 2024. 428 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Impact Partnership Wealth held 498 shares of United Therapeutics worth $270K as of Q3 2026.
  • Impact Partnership Wealth bought 113 United Therapeutics shares in Q3 2026, an estimated $58.4K.
  • United Therapeutics made up 0.02% of Impact Partnership Wealth's portfolio in Q3 2026, its #380 holding.
  • Impact Partnership Wealth first reported a position in United Therapeutics in Q4 2023 and has held it in 6 quarters since.
  • Impact Partnership Wealth's United Therapeutics position peaked at $344K in Q4 2024.
  • 428 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Impact Partnership Wealth's 13F filing for Q3 2026, filed 9 Nov 2026.